Patents by Inventor Claus Mueller

Claus Mueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10207695
    Abstract: A rail vehicle compressor system comprises a compressor, driven by an electrical machine via a drive shaft, for producing compressed air for at least one compressed air tank. The electrical machine is activated at least indirectly via a control device for operating the electrical machine at least one nominal speed between a maximum speed and a minimum speed. At least one pressure sensor determines the pressure for the control device and is disposed in a compressed-air-carrying line downstream of the compressor. A final control element for continuously influencing the speed of the electrical machine is disposed between an electrical supply and the electrical machine, wherein the control device controls activation of the final control element. A method for controlling the compressor system is also provided, wherein, the compressor is operated at a variable speed in between the maximum speed and the minimum speed based on rail vehicle operating state.
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: February 19, 2019
    Assignee: KNORR-BREMSE SYSTEME FUR SCHIENENFAHRZEUGE GMBH
    Inventors: Gert Assman, Thomas Kipp, Thomas Merkel, Karl Hering, Robert Frank, Claus Mueller
  • Publication number: 20170138401
    Abstract: A bearing element (1) for a plain or antifriction bearing is provided, the bearing element (1) being formed of or including at least sectionally a powder-metallurgical composite material which includes a metallic binder phase and a hard material phase, wherein the metallic binder phase is based on at least one element from the following group: chromium, cobalt, molybdenum, nickel, titanium.
    Type: Application
    Filed: March 3, 2015
    Publication date: May 18, 2017
    Inventors: Christian Schulte-Noelle, Claus Mueller, Yegor Rudnik
  • Publication number: 20160311420
    Abstract: A rail vehicle compressor system comprises a compressor, driven by an electrical machine via a drive shaft, for producing compressed air for at least one compressed air tank. The electrical machine is activated at least indirectly via a control device for operating the electrical machine at at least one nominal speed between a maximum speed and a minimum speed. At least one pressure sensor determines the pressure for the control device and is disposed in a compressed-air-carrying line downstream of the compressor. A final control element for continuously influencing the speed of the electrical machine is disposed between an electrical supply and the electrical machine, wherein the control device controls activation of the final control element. A method for controlling the compressor system is also provided, wherein, the compressor is operated at a variable speed in between the maximum speed and the minimum speed based on rail vehicle operating state.
    Type: Application
    Filed: December 2, 2014
    Publication date: October 27, 2016
    Inventors: Gert Assmann, Thomas Kipp, Thomas Merkel, Karl Hering, Robert Frank, Claus Mueller
  • Patent number: 9175726
    Abstract: A bearing module including a first bearing component and a second bearing component which are mounted such that the first bearing component and the second bearing component can move relative to one another, the first bearing component being an outer ring extending in a circumferential direction and the second bearing copmonent being a corresponding inner ring, a raceway is provided on one of the outer bearing and the inner bearing ring, and corrosion protection is provided at a side of the raceway, the corrosion protection being anodic corrosion protection and including one of a sacrificial anode or an impressed current anode. A separate protection means is provided, which is comprised of an oligodynamically acting material.
    Type: Grant
    Filed: May 5, 2009
    Date of Patent: November 3, 2015
    Assignee: Schaeffler Technologies AG & Co. KG
    Inventors: Eduard Beresch, Christian Schulte-Noelle, Claus Mueller, Ahmed Hafit
  • Patent number: 9133179
    Abstract: The invention relates to pyridine derivatives of Formula (I) wherein A, R1, R2, R3, and R4 are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: September 15, 2015
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Martin Bolli, Cyrille Lescop, Boris Mathys, Keith Morrison, Claus Mueller, Oliver Nayler, Beat Steiner
  • Patent number: 9000018
    Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: April 7, 2015
    Assignee: Actelion Pharmaceuticals, Ltd
    Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
  • Patent number: 8697732
    Abstract: The invention relates to novel pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: April 15, 2014
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Martin Bolli, David Lehmann, Boris Mathys, Claus Mueller, Oliver Nayler, Beat Steiner, Jörg Velker
  • Patent number: 8658675
    Abstract: The invention relates to pyridine derivatives of Formula (I), wherein A, R1, R2, R3, and R4 are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    Type: Grant
    Filed: July 15, 2010
    Date of Patent: February 25, 2014
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Martin Bolli, Cyrille Lescop, Boris Mathys, Keith Morrison, Claus Mueller, Oliver Nayler, Beat Steiner
  • Patent number: 8598208
    Abstract: The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituents are as defined in the claims.
    Type: Grant
    Filed: August 14, 2008
    Date of Patent: December 3, 2013
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Martin Bolli, Cyrille Lescop, Boris Mathys, Claus Mueller, Oliver Nayler, Beat Steiner, Jorg Velker
  • Patent number: 8592460
    Abstract: The invention relates to novel amino-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    Type: Grant
    Filed: February 29, 2008
    Date of Patent: November 26, 2013
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Martin Bolli, Boris Mathys, Claus Mueller, Oliver Nayler, Beat Steiner, Jorg Velker
  • Publication number: 20130310432
    Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
    Type: Application
    Filed: July 26, 2013
    Publication date: November 21, 2013
    Applicant: Actelion Pharmaceuticals Ltd.
    Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
  • Publication number: 20130303514
    Abstract: The invention relates to pyridine derivatives of Formula (I) wherein A, R1, R2, R3, and R4 are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    Type: Application
    Filed: January 18, 2012
    Publication date: November 14, 2013
    Applicant: ACTELION PHARMACEUTICALS LTD.
    Inventors: Martin Bolli, Cyrille Lescop, Boris Mathys, Keith Morrison, Claus Mueller, Oliver Nayler, Beat Steiner
  • Patent number: 8580824
    Abstract: The invention relates to pyridine derivatives of Formula (I) wherein A, R1, R2, R3, R4, R5, and R6 are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    Type: Grant
    Filed: September 6, 2007
    Date of Patent: November 12, 2013
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Martin Bolli, David Lehmann, Boris Mathys, Claus Mueller, Oliver Nayler, Beat Steiner, Jörg Velker
  • Patent number: 8575200
    Abstract: The invention relates to pyridine derivatives of Formula (I) wherein A, R1, R2, R3, R4, R5, R6 and R7 are as described in the description, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    Type: Grant
    Filed: February 25, 2009
    Date of Patent: November 5, 2013
    Assignee: Actelion Pharmaceuticals Ltd
    Inventors: Martin Bolli, Cyrille Lescop, Boris Mathys, Claus Mueller, Oliver Nayler, Beat Steiner
  • Patent number: 8524752
    Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: September 3, 2013
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
  • Patent number: 8410151
    Abstract: The invention relates to novel aminomethyl benzene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: April 2, 2013
    Assignee: Actelion Pharmaceuticals Ltd
    Inventors: Martin Bolli, Cyrille Lescop, Boris Mathys, Claus Mueller, Oliver Nayler, Beat Steiner
  • Publication number: 20120302612
    Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
    Type: Application
    Filed: August 9, 2012
    Publication date: November 29, 2012
    Inventors: Christoph BINKERT, Martin BOLLI, Boris MATHYS, Claus MUELLER, Michael SCHERZ, Oliver NAYLER
  • Patent number: RE43833
    Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
    Type: Grant
    Filed: August 9, 2011
    Date of Patent: November 27, 2012
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
  • Patent number: RE45174
    Abstract: The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: September 30, 2014
    Assignee: Actelion Pharmaceuticals Ltd.
    Inventors: Christoph Binkert, Martin Bolli, Boris Mathys, Claus Mueller, Michael Scherz, Oliver Nayler
  • Patent number: RE47980
    Abstract: Process for removing mercury from flue gases of high-temperature plants, in particular power stations and waste incineration plants in which a bromine compound is fed to the multistage furnace and/or the flue gas in a plant section downstream of the furnace, the temperature during contact of the bromine compound with the flue gas being at least 500° C., preferably at least 800° C. The combustion is carried out in the presence of a sulphur compound, in particular sulphur dioxide. Subsequently to the furnace, the flue gas is subjected to an optional multistage cleanup for removing mercury from the flue gas, which cleanup comprises a wet scrubber and/or a dry cleanup.
    Type: Grant
    Filed: March 16, 2015
    Date of Patent: May 12, 2020
    Assignee: Bromerc Limited
    Inventors: Bernhard Vosteen, Rico Kanefke, Ewa Kanefke, Claus Mueller, Michael Nolte, Heinz Koeser, Joachim Beyer, Theodore-Gerhard Bonkhofer, Olaf Fleth, Andrea Schnitzer, Andreas Pohontsch